Clinical Trials Directory

Trials / Completed

CompletedNCT00233922

Reconstruction of the Orbit With a Bioresorbable Polycaprolactone Implant

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
80 (estimated)
Sponsor
National University Hospital, Singapore · Academic / Other
Sex
All
Age
20 Years – 70 Years
Healthy volunteers
Accepted

Summary

Patients with orbital injuries are entered into the trial. Age: 20 - 70. After obtaining appropriate consent, they are entered into either a control arm where reconstruction of the orbit is done with a titanium mesh (established practice) or the experimental arm where reconstruction is by a bioresorbable implant made of polycaprolactone. Patients are followuped at 1 week, 1 month, 3 months, 6 months \& 12 months. CT scan of the orbits are performed preop, 6 months \& 12 months. End point is the 12 month follow-up appointment. Visual acuity, range of motion, enophthalmos \& diplopia are assessed in follow-up.

Detailed description

Patients with orbital injuries are entered into the trial. Age: 20 - 70. After obtaining appropriate consent, they are entered into either a control arm where reconstruction of the orbit is done with a titanium mesh (established practice) or the experimental arm where reconstruction is by a bioresorbable implant made of polycaprolactone. Patients are followuped at 1 week, 1 month, 3 months, 6 months \& 12 months. CT scan of the orbits are performed preop, 6 months \& 12 months. End point is the 12 month follow-up appointment. Visual acuity, range of motion, enophthalmos \& diplopia are assessed in follow-up.

Conditions

Interventions

TypeNameDescription
DEVICEOsteosheet(r)

Timeline

Start date
2004-07-01
Completion
2007-07-01
First posted
2005-10-06
Last updated
2008-05-13

Locations

1 site across 1 country: Singapore

Source: ClinicalTrials.gov record NCT00233922. Inclusion in this directory is not an endorsement.